FDA Grants Traditional Approval to TB Treatment Sirturo

The FDA has granted traditional approval to Sirturo® (bedaquiline) for use as part of combination therapy in adult and pediatric patients with pulmonary tuberculosis due to Mycobacterium tuberculosis resistant to at least rifampin and isoniazid.